BJB
4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid
Find entries where: BJB
is present as a standalone ligand in 4 entries
Chemical Component Summary | |
---|---|
Name | 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid |
Identifiers | 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloranyl-indol-2-yl]butanoic acid |
Formula | C19 H15 Cl N2 O4 S2 |
Molecular Weight | 434.916 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc2c(cc1S(=O)(=O)n3c4ccc(cc4cc3CCCC(=O)O)Cl)scn2 |
InChI | InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24) |
InChIKey | OQDQIFQRNZIEEJ-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 43 |
Chiral Atom Count | 0 |
Bond Count | 46 |
Aromatic Bond Count | 20 |
Drug Info: DrugBank
DrugBank ID | DB14801 |
---|---|
Name | Lanifibranor |
Groups | investigational |
Description | Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337). |
Synonyms | Lanifibranor |
Categories |
|
CAS number | 927961-18-0 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 68677842 |
ChEMBL | CHEMBL4091374 |